Medication errors remain a significant source of morbidity and mortality in the perioperative setting. This review synthesizes current evidence on the prevention of surgical medication errors across the perioperative continuum, emphasizing mechanisms, risk factors, diagnostic approaches, management strategies, and guideline-based recommendations. Recent advances and emerging therapies, along with practical, clinically relevant insights, are discussed to inform best practices for perioperative care teams.
Medication safety is a cornerstone of quality perioperative care, particularly given the complex, high-risk environment of surgical practice. The perioperative continuum encompassing preoperative, intraoperative, and postoperative phases presents multiple opportunities for medication errors due to rapid patient turnover, dynamic workflows, and the involvement of multidisciplinary teams. This article provides a comprehensive, evidence-based overview of strategies to prevent surgical medication errors, incorporating recent research, clinical guidelines, and practical recommendations relevant to daily practice.
Medication errors in surgery remain distressingly common, accounting for up to 5% of perioperative drug administrations, according to recent systematic reviews. Adverse drug events (ADEs) occur in approximately 1 in 20 perioperative medication administrations, with more than a third deemed preventable. The incidence is higher in high-acuity settings, such as cardiac surgery and trauma, and medication errors are linked to increased operative morbidity, prolonged hospital stays, and, in severe cases, mortality. The economic burden is significant, with medication-related harm contributing to increased healthcare costs and resource utilization globally.
Perioperative medication errors arise from complex interactions among human factors, system-level vulnerabilities, and the pharmacological properties of administered agents. Errors may occur at any stage: prescribing, transcribing, dispensing, administering, or monitoring. Common mechanisms include look-alike/sound-alike drugs, incorrect dosing or route, failure to adjust for renal or hepatic function, and breakdowns in communication, particularly during handovers. The pathophysiological consequences can range from minor, reversible effects to severe, life-threatening events such as anaphylaxis, respiratory depression, or cardiovascular collapse.
Risk factors for perioperative medication errors are multifactorial. Patient-related factors include extremes of age, comorbidities, polypharmacy, and impaired organ function. System-related risks involve inadequate labeling, poor storage practices, time pressure, fatigue, and interruptions during medication administration. Provider-related factors encompass insufficient training, unfamiliarity with protocols, and cognitive overload. Emergency surgeries and after-hours procedures are independently associated with higher error rates.
Clinical manifestations of perioperative medication errors vary widely based on the drug involved, dose, and patient susceptibility. They may be immediately evident (e.g., acute hypotension from overdose of anesthetic agents) or insidious (e.g., postoperative delirium due to anticholinergic toxicity). Non-specific signs such as unexpected hemodynamic instability, respiratory depression, allergic reactions, and altered mental status may prompt investigation for a medication error. Prompt recognition is essential to mitigate harm.
Diagnosis of medication errors in the perioperative environment often relies on high clinical suspicion and thorough review of perioperative events. Root cause analysis, incident reporting systems, and real-time audits aid in identifying errors. Laboratory investigations may be necessary to detect drug levels, metabolic disturbances, or toxicities. Multidisciplinary debriefings and checklists are increasingly utilized to systematically review perioperative care and uncover latent errors.
Immediate management of perioperative medication errors centers on stabilizing the patient and mitigating adverse effects. This may include administration of antidotes (e.g., naloxone for opioid overdose), supportive measures (airway management, hemodynamic support), and withdrawal of the offending agent. Documentation and transparent communication with the patient and family are critical. Post-event analysis is essential for system improvement and prevention of recurrence.
Technological innovations have shown promise in reducing perioperative medication errors. Barcode medication administration, electronic prescribing, and automated anesthesia information management systems enhance accuracy and traceability. Smart infusion pumps, standardized drug labeling, and color-coded syringes minimize selection and dosing errors. Simulation-based team training and cognitive aids, such as checklists and decision-support tools, have demonstrated efficacy in improving medication safety. Artificial intelligence and real-time analytics are emerging as tools to predict and prevent errors before they reach the patient.
Major anesthesia and surgical societies, including the American Society of Anesthesiologists and the World Health Organization, advocate for a multifaceted approach to medication safety. Key recommendations include protocolized medication workflows, double-checks for high-risk drugs, clear labeling and segregation of medications, routine staff education, and active incident reporting cultures. Implementation of perioperative medication safety bundles, tailored to institutional resources and patient populations, is strongly endorsed. Engagement of pharmacists in the perioperative team further enhances safety and compliance with best practices.
Preventing surgical medication errors across the perioperative continuum requires a comprehensive, system-based approach grounded in evidence and best practices. Awareness of risk factors, vigilant monitoring, adoption of technology, and adherence to standardized protocols are integral to optimizing patient safety. Ongoing education, multidisciplinary collaboration, and a culture of transparency and continuous improvement remain essential to reduce the burden of medication errors in perioperative care.
1.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
2.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
3.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
4.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
5.
Renewing the call for a national Cancer Patient's Bill of Rights
1.
Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells
2.
Tumor Evolution Forecasting for Precision Oncology Decisions
3.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
4.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
5.
Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Managing Common Side Effects During Cancer Treatment
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation